OBJECTIVES: Transthoracic oesophagectomy is associated with high morbidity and mortality. Some oesophageal cancer (OC) patients with serious comorbidities cannot tolerate transthoracic oesophagectomy. Therefore, we have adopted a minimally invasive approach to oesophagectomy for such patients.
INTRODUCTION
Oesophageal cancer (OC) is one of the most common malignant tumours with high morbidity and mortality, and is a leading cause of death [1, 2] . The worldwide incidence of OC has been increasing every year [3] . Oesophageal resection remains the cornerstone of OC treatment. In transthoracic oesophagectomy, including thoracoscopic oesophagectomy, it is necessary to collapse one of the lungs. Transthoracic oesophagectomy is associated with a high rate of postoperative morbidity and mortality [2, 4] . Some OC patients have serious comorbidities, and cannot tolerate transthoracic oesophagectomy.
Mediastinoscopy-assisted oesophagectomy (MAO), which avoids thoracotomy, is adopted for OC patients with serious comorbidities, such as pulmonary and cardiovascular diseases, to reduce postoperative morbidity and mortality. MAO was first reported by Buess in 1990 [5] . MAO has been performed for OC treatment in our hospital since 2005. The clinical data of 70 T1 OC patients with serious comorbidities who underwent MAO from January 2007 to January 2010 were retrospectively analysed in this study. The aim of this study was to assess the perioperative complications and survival rate of these patients. We also analysed factors, such as tumour length, lymphatic metastasis and infiltration depth, that affected the overall 5-year survival rate of these patients.
MATERIALS AND METHODS
Lung function was measured by blood gas analysis and standard spirometry before surgery. The degree of airway limitation was assessed according to the Global Initiative for Chronic Obstructive Lung Disease. Blood biochemistry, coagulation indices and haemoglobin A1c were also examined before surgery. The ChildPugh score and 24-h creatinine clearance were used to measure liver and kidney functions. Postoperative complications were evaluated as previously described [6] .
Eighty-five OC patients, who could not tolerate transthoracic oesophagectomy, received MAO from January 2007 to January 2010 in our hospital. All investigational sites had Institutional Review Board approval, and all patients provided voluntary informed consent to undergo surgery. The clinical data of 70 T1 OC patients, confirmed by pathological examination, were retrospectively analysed in this study. Patients who received neoadjuvant chemotherapy or radiotherapy or were found to have distant metastasis by preoperative examination were excluded from this study. Patients who had previously received endoscopic therapies were also excluded.
Surgical procedure
All patients underwent detailed history-taking and physical examinations before the surgery. The diagnoses were confirmed by gastric endoscopy and endoscopic ultrasonography. CT scans of the cervical region, thorax and upper abdomen were performed in all patients, and 10 patients received PET-CT examination before the surgery.
The surgical procedure was performed as described before [7] . During surgery, patients were in the supine position, under general anaesthesia with endotracheal intubation. Via a left cervical approach (Fig. 1A) , the cervical oesophagus was exposed carefully under direct vision. The mediastinoscope was inserted into the upper mediastinum along the side of the oesophagus. The mediastinoscope was used to dissect the oesophagus on the anterior, posterior, left and right side of the oesophagus (Fig. 1C  and D) . The cervical oesophagus was pulled to the left side when isolating the thoracic oesophagus on the right side. During the process of isolating the oesophagus, the oesophageal artery was treated with titanium clips (Fig. 1E and F) . The mediastinal lymph node was dissected by using electric coagulation/aspiration and biopsy forceps ( Fig. 1G and H) . On the right side of the oesophagus, the right laryngeal nerve could be exposed. On the left side of the oesophagus, the left laryngeal nerve could also be exposed. In some patients, the thoracic duct could be seen on the posterior side of the oesophagus. If necessary, surgical ligation with titanium clips could be used for thoracic duct injury. The epigastric mid-line incision was used to dissociate the stomach and clear away the abdominal lymph nodes as an open surgery (Ivor Lewis oesophagectomy). The seromuscular layers of the lesser curvature were sutured (Fig. 1B) . The isolated oesophagus and stomach were drawn from the cervical incision along the oesophageal bed. Oesophagogastric anastomosis by the hand-sewn method was performed during the surgery. Laparoscopy and gastric tube were avoided to reduce costs.
Pathological examination
The tumour length of all resected specimens was measured immediately after oesophagectomy. The tumour mass and lymph nodes were processed by formalin fixation and mineral wax embedment. Routine pathology was performed to assess the infiltration depth and lymphatic metastasis. The seventh edition of the UICC-AJCC TNM classification for OC was used for the postoperative pathological staging.
Statistical analysis
The patients were followed up until October 2013 by re-diagnosis, telephone calls and letters. Data were presented as mean ± SD. The main end-point of this study was the overall survival (OS). A commercially available statistical software package SPSS 17.0 (SPSS, Inc., USA) was used. The impact of tumour diameter, infiltration depth and lymph node metastasis on survival rate was analysed by the Kaplan-Meier method and Cox regression.
RESULTS

Patient characteristics
Seventy patients with OC, who were confirmed to be in T1 stage by pathological examination after surgery, were enrolled in this study. The main comorbidities of the patients are given in Table 1 . Some patients had pulmonary diseases (58 cases), cardiovascular diseases (12 cases), cerebral infarction (4 cases), chronic kidney disease (2 cases), chronic hepatic diseases (8 cases) and diabetes (15 cases). The main laboratory examinations before surgery are given in Table 2 .
Of the 70 patients, 46 were males and 24 were females. The median age was 68.5 years (60-83 years). The postoperative pathology of the specimens revealed that 66 patients had squamous cell carcinoma (94.2%), 2 had sarcoma (3.0%), 1 patient had poorly differentiated carcinoma (1.4%) and 1 patient had neuroendocrine carcinoma (1.4%). According to the latest classification for EC, 27 patients had T1a EC and 43 patients had T1b EC. Sixty-one patients were in stage N0 and 9 patients were in stage N1. There were no patients in N2-3 stage (Table 1) .
Perioperative conditions
The intraoperative and postoperative complications are listed in Table 3 . The average operation time was 150.0 ± 15.0 min, and the mean perioperative bleeding volume was 202.0 ± 12.8 ml. Five cases were found with anastomotic leakage at 3 days after surgery. By open drainage, the fistula of these patients was closed at 14 days after surgery. Four patients developed pneumonia after the surgery, and were treated with good airway management and anti-infective therapy. One patient had chylothorax and was cured by conservative treatment. Two patients had recurrent laryngeal nerve injury after operation and recovered within 1 month. Three cases suffered from wound infection, and were cured by wound care. The median postoperative hospital stay was 10 (7-22) days. The number of lymph nodes resected was 13.8 ± 4.4. The mean number of cervical, mediastinal and abdominal lymph nodes resected was 0.5 ± 0.2, 4.2 ± 0.8 and 9.2 ± 2.2, respectively. No patient died during hospitalization (Table 3) .
Five-year outcomes
All patients were followed up until death or October 2013. The median follow-up duration of the patients was 48 (10-71) months. The 3-year OS rate was 81% [95% confidence interval (CI): 70-89%] and the 5-year OS rate was 71% (95% CI: 56-81%) ( Fig. 2A) . Among the 17 patients who died, 2 died of anastigmatic recurrence, 14 died of distance metastasis and 1 patient died of chronic obstructive pulmonary disease. No anastomotic stenosis was found during the follow-up period.
Analysis of prognosis for 5-year survival rate
The tumour length ranged from 0.5 to 6.0 cm; with a median of 2.0 cm. The patients were divided into two groups (<2 vs ≥2 cm). For patients with tumour length <2 cm, the 5-year OS was 80%, and for those with tumour length ≥2 cm, the 5-year OS rate was 57% (P = 0.0084) (Fig. 2B) . Lymphatic metastasis is an important prognostic factor for patients with OC. In this study, 9 patients were in N1 stage and 61 were in N0 stage. The 5-year OS rate for the N0 group was 73% and for the N1 group 53% (P = 0.037) (Fig. 2C ). There were 27 patients with T1a EC and 43 patients with T1b EC in this study. The 5-year survival rate for the T1a (N0/N1) group was 85% and for T1b (N0/N1) group 62% (P = 0.0242) (Fig. 2D) . The Cox regression model was used to analyse the effect of independent factors on the survival prognosis of the patients. Multivariate analysis by Cox regression showed that lymph node metastasis and tumour length were independent prognostic factors for OC patients (P <0.05) ( Table 4) .
DISCUSSION
As one of the most common malignancies, OC frequently occurs with high mortality in most countries. The major pathological type of OC in East Asia is squamous cell carcinoma [8] . In this study, 66 patients suffered from squamous cell carcinoma (94.3%). Surgery is one of the most important ways to treat patients with localized lesion of OC. Transthoracic oesophagectomy is the main traditional surgical approach for OC treatment. Transthoracic oesophagectomy is associated with a wide range of complications, and a high rate of hospitalization death. The mortality rate of traditional oesophagectomy is 2.5-20.3% [9] , and 30-50% of the patients may suffer from serious postoperative complications [10] . Some OC patients with serious comorbidities cannot tolerate transthoracic oesophagectomy [11] . Transhiatal oesophagectomy (THO) is [12] . With the advancement of technology, minimally invasive surgery such as MAO was used in oesophageal surgery. MAO is performed under direct vision and may be safer than THO [12] . Seventy T1 OC patients with serious comorbidities received MAO in this study. No perioperative death occurred in this study. The rate of serious complications was 14.28% (10/70) . Our data demonstrated that MAO could be safely performed in T1 OC patients. The morbidity and complications of the procedure were acceptable, and similar to or even better than most published methods of open oesophagectomy [13] .
The 5-year survival rate for patients with T1N0 OC was reported to be 65-80% after traditional surgery [14, 15] . The 5-year survival rate for patients with T1N1 OC who underwent traditional surgery was 40% [16] . There were 61 patients with T1N0 OC and 9 patients with T1N1 OC in our study. The overall 5-year survival rate was 73% for patients with T1N0 OC and 53% for patients with T1N1 OC. These results showed that patients with both T1N0 and T1N1 OC who received MAO treatment had an optimistic 5-year survival rate. According to the latest oesophageal TNM classification, at least 15 lymph nodes in each resection specimen are needed for reliable N staging. The mean number of resected lymph nodes for each patient was 13.8 ± 4.4 in our study, which may involve a risk of tumour under-staging. Lymph node dissection in OC remains controversial [17] . Most studies in recent years reported that more lymph node dissections correlated with better survival time [18] , while some previous studies reported that lymphadenectomy showed no benefit with regard to survival time [19, 20] . Insufficient number of lymph node resections may be a major limitation of MAO treatment for OC [7] . The limitations of tumour under-staging and insufficient number of lymph node resections could be solved in the near future by enhancing the surgical technique and/or the surgical equipment for MAO.
Multivariate analysis by Cox regression showed that lymph node metastasis and tumour length were independent prognostic factors for the patients in this study (P <0.05) ( Table 4 ). Previous studies have also shown significant differences in 5-year outcomes between the groups with tumour length <2 cm and ≥2 cm for patients with T1 OC [21, 22] . In our study, the 5-year survival rate was 80% for patients with tumour length <2 cm and 57% for those with tumour length ≥2 cm. As an index for longitudinal growth of tumour, tumour length may be one of the main prognostic factors for patients with OC. Lymph node metastasis is an independent risk factor for EC prognosis [22] . The 5-year survival rate was 73% for patients with T1N0 OC and 53% for patients with T1N1 OC in our study. Previous studies have shown that the 5-year survival rate was 65-80% for patients with T1N0 OC and 40% for patients with T1N1 OC [14] [15] [16] 23] . The results showed that lymph node metastasis was an important factor affecting the survival rate of patients with OC.
Previous studies have shown that the risk for lymph node metastases was 0% for OC limited to the mucosal layer and 16-22% for OC that had invaded into the sub-mucosal layer [24] . The lymph node metastasis rate was reported to be 6% for T1a and 17.5% for T1b EC [25] . The lymph node metastasis rate was 3.7% (1/27) for patients with T1a OC and 18.6% (8/43) for patients with T1b OC in our study (Table 1) . Endoscopic sub-mucosal dissection (ESD) and endoscopic mucosal resection (EMR) are currently used to treat patients with T1 OC. Our procedure might be too radical for a T1a tumour, which carries a very low risk of lymphatic dissemination, and therefore can be treated by organ-preserving EMR-ESD.
This was a retrospective study at a single centre. To confirm these findings, randomized controlled multicentre clinical trials are needed.
MAO could be performed for T1 OC patients with serious comorbidities who cannot tolerate transthoracic oesophagectomy. MAO is performed under direct vision and may be safer than THO. Lymph node metastasis and tumour length were independent prognostic factors for these patients in this study.
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